CURE

CHICKEN SALAD CHICK SUCCESSFULLY EXPANDS FOOTPRINT, MENU IN 2023

Retrieved on: 
Monday, February 26, 2024

ATLANTA, Feb. 26, 2024 /PRNewswire/ -- Chicken Salad Chick, the nation's only fast casual chicken salad restaurant concept, continues to experience a consistent trajectory of growth as the brand sets its sights on another year of aggressive expansion in 2024. Closing out 2023 with 32 new restaurants opened, a more than 33 percent total unit count increase from the previous year, Chicken Salad Chick expanded its presence with new locations across 14 states, including Texas, Florida, North Carolina and Georgia. This expansion notably included the introduction of the first-ever Chicken Salad Chick in Colorado, making the fast casual concept now available in 18 states. The brand also signed 18 franchise agreements with both new and existing franchisees to develop 53 new restaurants over the next several years throughout states like Texas, Oklahoma, Illinois, Ohio, Virginia and Maryland.

Key Points: 
  • This expansion notably included the introduction of the first-ever Chicken Salad Chick in Colorado, making the fast casual concept now available in 18 states.
  • The hot new item can be customized by selecting from Chicken Salad Chick's 12+ chicken salad flavors or pimento cheese, combined with provolone cheese and served on a toasted, buttery croissant.
  • Using state-of-the-art toaster technology, Chicken Salad Chick achieves the perfect fusion of a golden-brown, crispy exterior and a gooey, melted interior, providing a delightful new way to enjoy the brand's renowned made-from-scratch chicken salad flavors.
  • "Chicken Salad Chick has grown through the years with wonderful franchisees and corporate team members who share our purpose of spreading joy, enriching lives and serving others," said Scott Deviney, CEO of Chicken Salad Chick.

Inaugural Award Poised to Advance Treatment Options for Uveal Melanoma Patients

Retrieved on: 
Friday, February 16, 2024

WASHINGTON , Feb. 16, 2024 /PRNewswire-PRWeb/ -- The Melanoma Research Foundation (MRF) recently announced the winners of the inaugural CURE OM Options Bring Hope Team Science Award: Bruce Ksander, PhD from the Schepens Eye Research Institute; Rizwan Haq MD, PhD from the Dana-Farber Cancer Institute and Margarete Karg, PhD from Massachusetts Eye and Ear Infirmary. The collaborative research project is titled, "Identification of molecular pathways that drive uveal melanoma metastasis." The goal of the team's research is to determine the main factors that drive uveal melanoma (UM) to spread and specifically target the liver, with the hope that this research may guide the development of effective therapeutic interventions. Uveal melanoma is a type of ocular melanoma (OM) and is the most common type of eye cancer in adults that constitutes around 5 of all melanomas. In about half of all UM cases, the disease will spread to other parts of the body. When this occurs, it is almost always fatal.

Key Points: 
  • The collaborative research project is titled, "Identification of molecular pathways that drive uveal melanoma metastasis."
  • Uveal melanoma is a type of ocular melanoma (OM) and is the most common type of eye cancer in adults that constitutes around 5 of all melanomas.
  • The CURE OM Options Bring Hope Team Science Award intends to support an interdisciplinary research team who is researching treatment options for metastatic UM patients not limited by HLA type.
  • To learn more about the CURE OM Options Bring Hope Team Science Award, read here .

Grant’s Inaugural Private Credit Event to Examine Risks and Opportunities in Fast-Growing Market

Retrieved on: 
Tuesday, February 13, 2024

Grant's Interest Rate Observer today announced a major private-credit event to weigh risks and opportunities in the most talked-about, fastest-growing and perhaps most-misunderstood branch of the debt markets.

Key Points: 
  • Grant's Interest Rate Observer today announced a major private-credit event to weigh risks and opportunities in the most talked-about, fastest-growing and perhaps most-misunderstood branch of the debt markets.
  • Speakers, comprising a who’s who of investors, dealmakers, and thinkers, will explore the income opportunity, systemic risks, and cyclical-test-to-come in the $1.5 trillion entity.
  • James Grant, founder and editor of Grant’s Interest Rate Observer, said: “The burgeoning private credit market sits today at the intersection of heavy leverage and elevated interest rates.
  • We’re delighted to bring together the brightest minds to help investors seize the opportunities and steer clear of the hazards.”
    For more information on Grant's and the private credit event, which can be attended in-person or virtually, please visit www.grantspub.com/events .

CURE Media Group announces winners of the 2023 MPN Heroes® Recognition Program

Retrieved on: 
Saturday, December 9, 2023

CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced the recipients of the 2023 MPN Heroes® Recognition Program.

Key Points: 
  • CRANBURY, N.J., Dec. 08, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced the recipients of the 2023 MPN Heroes® Recognition Program.
  • Marilyn Kay Edwards is an MPN Hero for her outreach as an MPN peer with CHAMPN, the Community Voice Champion Program.
  • Marina Kremyanskaya, M.D., Ph.D., is an MPN Hero because of her extraordinary impact as an educator, physician and leader in MPN research.
  • Incyte partners with CURE Media Group to support the program, with CURE hosting the annual MPN Heroes recognition ceremony.

CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program

Retrieved on: 
Thursday, November 16, 2023

CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced that Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda is the keynote speaker for the 2023 MPN Heroes recognition program. The event will be held December 8 in conjunction with the American Society of Hematology Annual Meeting and Exposition in San Diego, California.

Key Points: 
  • CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) -- CURE Media Group, the industry-leading multimedia platform devoted to providing cancer updates and research to more than 1 million patients, survivors and caregivers, today announced that Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda is the keynote speaker for the 2023 MPN Heroes recognition program.
  • Academy Award-winning actor, author, producer, political activist and fitness guru Jane Fonda, is the keynote speaker for CURE Media Group's 2023 MPN Heroes recognition program.
  • “We are truly honored to have Jane Fonda as our keynote speaker for the 2023 MPN Heroes recognition program,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences®, the parent company of CURE.
  • For more information on the 2023 MPN Heroes recognition program, click here .

Los Angeles' Leading Vacation Rental Manager, Stay Awhile Villas, Announces Exclusive Partnership with CURE

Retrieved on: 
Thursday, December 14, 2023

LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- Stay Awhile Villas , a leading name in the luxury vacation rental industry founded by Stuart Heller, announced today an exclusive partnership with CURE , a renowned wellness and healthcare provider led by Dr. Lisa Benya.

Key Points: 
  • LOS ANGELES, Dec. 14, 2023 /PRNewswire/ -- Stay Awhile Villas , a leading name in the luxury vacation rental industry founded by Stuart Heller, announced today an exclusive partnership with CURE , a renowned wellness and healthcare provider led by Dr. Lisa Benya.
  • All Stay Awhile guests will now have complimentary access to CURE's exclusive private members-only clubhouse during their stay.
  • As of today, guests with reservations at any Stay Awhile Villas property will have access to CURE with their reservation.
  • The partnership between Stay Awhile Villas and CURE marks a significant milestone in the hospitality industry.

Custard Companies Reflects on Year of Charitable Giving

Retrieved on: 
Monday, November 20, 2023

RW Custard states, "It is an honor to support these and other charities, not only during the holidays, but year-round."

Key Points: 
  • RW Custard states, "It is an honor to support these and other charities, not only during the holidays, but year-round."
  • Custard, Founder and Chairman Emeritus of Custard Companies, recognized the importance of sharing his growth and success with not only his employees, but also his community.
  • Providing volunteer time, funds and support, Custard has taken this cause to heart by sponsoring luncheons, golf outings and providing financial support.
  • In addition to CURE, Custard Companies also provides support to various other organizations across the county.

The CURE Brand To Introduce its Suite of Wellness Consumer Products to Asia

Retrieved on: 
Tuesday, November 14, 2023

NEW YORK, Nov. 14, 2023 /PRNewswire/ -- The CURE BRAND ("CURE" or the "Company"), an international lifestyle brand for the modern CBD consumer, today announced that it has entered into a joint partnership with Hirokazu Yamura, CEO of AJP Co Ltd, to introduce its portfolio of carefully sourced CBD products into retail and e-commerce marketplaces across Asia's fastest-growing market — Japan.

Key Points: 
  • Founded in 2019, CURE is a New York-based CBD wellness company led by Roland Nesi, founder of Roar Organic, and Health/Wellness expert Saf Sadiq.
  • "We are thrilled to bring the benefits of CURE products to consumers in Japan," said Saf Sadiq, CEO of CURE.
  • "Premium quality CBD products are now a global demand, as we've recently seen in Europe and other parts of the world.
  • We now have the privilege to partner with Hiro Yamura to provide Asian consumers with our plant-powered alternative products."

CHICKEN SALAD CHICK OPENS FIFTH MEMPHIS, TENNESSEE-AREA LOCATION IN ARLINGTON

Retrieved on: 
Monday, October 23, 2023

ATLANTA, Oct. 23, 2023 /PRNewswire/ -- Chicken Salad Chick, the nation's only fast casual chicken salad restaurant concept, announced today the opening of its newest Memphis-area location in Arlington, Tennessee. The new Chick marks the brand's fifth restaurant in the Memphis metro area and 22nd in the state. Boasting a drive-thru and outdoor patio, Chicken Salad Chick Arlington is located at 5291 Airline Road in The Falls shopping center. The community is invited to celebrate the grand opening on Wednesday, Nov. 1; the first 100 guests that morning will win free chicken salad for a year.  

Key Points: 
  • ATLANTA, Oct. 23, 2023 /PRNewswire/ -- Chicken Salad Chick , the nation's only fast casual chicken salad restaurant concept, announced today the opening of its newest Memphis-area location in Arlington, Tennessee.
  • During grand opening week, Arlington guests can expect to experience the Southern hospitality that Chicken Salad Chick is known for, with specials and giveaways that include:
    Wednesday, Nov. 1 – Free Chicken Salad for a Year to the first 100 Guests – The first guest in line will receive one large Quick Chick of chicken salad per week for an entire year.
  • **
    "Chicken salad is a staple in the South, and Memphis has really embraced Chicken Salad Chick's devotion to making this classic fresh from scratch every day in our restaurants and serving it with heart," said Scott Deviney, CEO of Chicken Salad Chick.
  • Chicken Salad Chick raises funds for organizations throughout the year, including annual programs such as Cookies for a CURE and the Chicken Salad Chick Foundation Giving Card.

EQS-News: Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology

Retrieved on: 
Monday, September 25, 2023

Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction.

Key Points: 
  • Atriva Therapeutics and Canadian Biocure Technologies, Inc. entered into an exclusive letter agreement for a reverse takeover transaction.
  • Shareholders of Atriva will receive not less than 75% of the securities of the resulting issuer, with the current shareholders of Biocure Technology holding the remainder.
  • Tübingen/Martinsried, Germany – September 18, 2023 – Atriva Therapeutics GmbH (“Atriva”) is pleased to disclose the signing of an exclusive letter agreement, dated September 14, 2023, with Biocure Technology Inc. (“CURE”) (CSE: CURE), based in Vancouver, Canada.
  • “This letter agreement underscores our commitment to leverage this transaction with CURE as an attractive growth option for Atriva and its stakeholders.